Research fields include translational research, invasion, metastasis, disseminated tumor cells, transcription, tumor-associated proteolysis, targeted therapy, micro-RNA, molecular staging of cancer. Associate Editor of the International Journal of Cancer, and on the Editorial Boards of: Advances in Medical Sciences, Journal of Cellular and Molecular Medicine, Frontiers in Molecular and Cellular Oncology, The Open Surgical Oncology Journal.
Training: Dental Research, Bioengineering.
Postdoctoral: TGF-beta, wound healing, regeneration, radiation biology, light biology, stem cells, biomaterial, Lasers.
Current: Clinical translational research and Molecular mechanisms.
Positions: President, NAALT; Chair SPIE, Chair ALD; Chair ASLMS.
Interests: Signal Transduction, Lasers, Biological regulation.
Director of the Cambridge Centre for Neuropsychiatric Research at Cambridge University. Practising clinician (with an Honorary Consultant position in General Adult Psychiatry at Addenbrookes Hospital, Cambridge). Co-founder of Psynova Neurotech Ltd. Professor for Tranlational Neuroscience at Erasmus University Medical Centre, Department of Neuroscience, Rotterdam.
Vice President for Translational Research, The University of Texas MD Anderson Cancer Center, Houston, TX; Harry Carothers Wiess Distinguished University Chair for Cancer Research, Rosalind Franklin Award for Excellence in Ovarian Cancer Research, Ovarian Cancer National Alliance; Award for Excellence in Gynecologic Oncology, International Gynecologic Cancer Society.
Professor, Director of the Division of Biostatistics & Medical Informatics, Department of Epidemiology and Public Health, University of Maryland - Baltimore. Adjunct professor University of Copenhagen, Denmark. 20+ awards and honors incl. ESTRO Gold Medal, MD Anderson Distinguished Alumnus Award, Honorary Life member Assoc. of Radiation Oncologists of India & Belgian Soc. for Therapeutic Radiology and Oncology. 370+ publications, H-index 62 Web of Science.
I am a neuropsychiatrist who also completed a movement disorders fellowship at Washington University. My research is primarily focused on neuroimaging and dopamine, especially in people with Tourette syndrome and Parkinson disease. I have also developed methods for structural imaging volumetry, analysis of brain images in nonhuman species, pharmacological fMRI (phMRI), and statistical analysis of anatomy-function relationships in deep brain stimulation (DBS).
A.W. and Mary Margaret Clausen Distinguished Professor and Director, Hormone Research Institute. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences and Ntional Academy of Medicine. Dr. Bluestone has spent over 35 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.
Prof. George P Chrousos is internationally recognized for his research on the glucocorticoid signaling system of the cell, on the diseases of the hypothalamic-pituitary-adrenal axis, and on the physiological and molecular mechanisms of stress. He is one of the 250 most cited scientists internationally (ISI highly cited) included not only in the list of Clinical Medicine, but also in that of Biology and Biochemistry, and the highest cited clinical endocrinologist and pediatrician in the world.
Professor of Pathology and Immunology at the University of Verona, Italy. Has long-standing expertise in vascular inflammation and leukocyte trafficking with particular focus on the central nervous system. M.D. degree and Residency in Neurology from the University of Milan and Ph.D. degree from the University of Verona. For her neuroimmunology studies she received several national and international awards. Elected in the AcademiaNet for excellent woman academics.
Fulvio D’Acquisto trained in Experimental Pharmacology during his PhD. After his post-doctoral training at Yale University (1999-2003) he joined the William Harvey Research Institute and was awarded the New Investigator Award of the MRC in 2004. He was appointed as Senior Lecturer in 2006, Reader in 2009 and Professor of Immunopharmacology in 2014. He is the Deputy Director of the Centre for Biochemical Pharmacology and Biomedical Research Theme co-Lead for the Life Science Institute.
Tampere University of Technology. Head of the Computational Medicine and Statistical Learning Laboratory.
Graduated in toxicology at the University of Lausanne, then trained at the Occupational Health Science Institute and at the Swiss Experimental Cancer Institute, and at the National Cancer Institute, USA. Main interest is cancer-related inflammation with special focus on mesothelioma. Principal investigator of translational research projects for the treatment of patients with mesothelioma, and non-clinical studies, which aim at a better understanding of the biology of mesothelioma development.